Vivpro Corporation
Accelerating Drug Development with AI
Vivpro offers a revolutionary biointelligence software platform and innovative services to accelerate evidence-based decisions for pharmaceutical, biotech, device developers, CROs and investors. The Knowledge Layer on your data assets provides superior intelligence to convert information into knowledge for critical business decisions across clinical, regulatory, strategy and investment. Vivpro's proprietary curated data and AI models drive faster, better quality decisions across the product development value chain. Vivpro brings fresh innovation to transform traditional pharma processes.Vivpro's platform unlocks R&D intelligence, powers faster decisions, enables better quality, provides smarter technology and superior strategy. Vivpro helps reimagine drug development.
Accelerating Drug Development with AI
Vivpro offers a revolutionary biointelligence software platform and innovative services to accelerate evidence-based decisions for pharmaceutical, biotech, device developers, CROs and investors. The Knowledge Layer on your data assets provides superior intelligence to convert information into knowledge for critical business decisions across clinical, regulatory, strategy and investment. Vivpro's proprietary curated data and AI models drive faster, better quality decisions across the product development value chain. Vivpro brings fresh innovation to transform traditional pharma processes.Vivpro's platform unlocks R&D intelligence, powers faster decisions, enables better quality, provides smarter technology and superior strategy. Vivpro helps reimagine drug development.
Show More
Recommendations (1)
All (1)
Recommendations (0)
Reviews (1)
Videos (0)
1 year ago
0
0
wrote a recommendation for
Unique means of applying AI to regulatory documents with the ability to address 'needle in the hackstack' queries. Very responsive. Forward thinking.
Sorry, but this listing is on a subscription plan which does not allow users to schedule meetings with them
Sorry, but this listing is on a subscription plan which does not allow users to view their website URL